Imaging of the Glucose

Imaging and radiotherapy targeting the glucose-dependent insulinotropic polypeptide receptor (GIPR) could potentially benefit the management of neuroendocrine neoplasms (NENs), complementing clinically established radiopharmaceuticals. The aim of this study was to evaluate a GIPR-targeting positron emission tomography (PET) radioligand with receptor-specific binding, fast blood clearance, and ...

The glucose-dependent insulinotropic polypeptide receptor (GIPR) is an emerging therapeutic and diagnostic target. Its endogenous ligand is the glucose-dependent in-sulinotropic polypeptide (GIP), which is a 42-mer peptide released from the intestinal K-cells in response to food intake.
(PDF) Imaging of the Glucose

Imaging and radiotherapy targeting the glucose-dependent insulinotropic polypeptide receptor (GIPR) could potentially benefit the management of neuroendocrine neoplasms (NENs), complementing ...
The glucose-dependent insulinotropic polypeptide receptor (GIPR) is an emerging therapeutic and diagnostic target. Its endogenous ligand is the glucose-dependent insulinotropic polypeptide (GIP), which is a 42-mer peptide released from the intestinal K-cells in response to food intake.

Characterization of 111In
Many NETs, expressing low somatostatin receptor levels, express glucose-dependent insulinotropic polypeptide (GIP) receptors (GIPR). Here, we evaluated the performance of [Lys 37 (DTPA)]N-acetyl-GIP 1-42, a newly synthesized GIP analogue to investigate whether NET imaging via GIPR targeting is feasible.
Imaging and radiotherapy targeting the glucose-dependent insulinotropic polypeptide receptor (GIPR) could potentially benefit the management of neuroendocrine neoplasms (NENs), complementing clinically established radiopharmaceuticals.

The Glucose
glucose-dependent insulinotropic polypeptide receptor (GIPr) neuroendocrine tumors (NETs) 111 In 68 Ga imaging The regulatory peptides and their receptors have gained an important role in the targeted imaging and radionuclide therapy of cancer over the last few decades. Overexpression of the receptors on the surface of cancer cells, in combination with their considerably low expression in ...
The Glucose-Dependent Insulinotropic Polypeptide Receptor: A Novel Target for Neuroendocrine Tumor Imaging—First Preclinical Studies Eleni Gourni1-3, Beatrice Waser4, Pascal Clerc5, Daniel Fourmy5, Jean Claude Reubi4, and Helmut R. Maecke2

Key Details About Imaging Of The Glucose Dependent Insulinotropic Polypeptide
Glucose-dependent insulinotropic polypeptide (GIP) was the first incretin identified and plays an essential role in the maintenance of glucose tolerance in healthy humans. Until recently GIP had not been developed as a therapeutic and thus has been ...








Glucose-dependent insulinotropic polypeptide (GIP) was the first incretin identified and plays an essential role in the maintenance of glucose toleran…